Skip to main
ASPI

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes is a progressive company with successful revenue streams and future growth plans, including entry into the global radiopharmaceutical and nuclear fuel markets. Their subsidiary, PET Labs, is facing production delays, but a potential spin-off of Quantum Leap Energy and expansion into Iceland and human trials for cancer treatment show promising opportunities. Although the CEO's medical condition may impact travel plans, the company is well-positioned for continued success in the future.

Bears say

ASP Isotopes is a relatively new company, incorporated in 2021, that is still in the development stage and is focused on scaling production and commercializing its proprietary isotope enrichment technologies. Despite its unique technological advantages and strategic partnerships, the company is facing challenges with management changes and uncertainties surrounding its Phase 2 helium project, leading to a negative outlook on the stock.

ASPI has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Buy based on their latest research and market trends.

According to 2 analysts, ASPI has a Buy consensus rating as of May 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.